ProShare Advisors LLC Has $86.72 Million Stake in Oracle Corporation $ORCL

ProShare Advisors LLC boosted its stake in shares of Oracle Corporation (NYSE:ORCL) by 12.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 396,649 shares of the enterprise software provider’s stock after buying an additional 43,375 shares during the quarter. ProShare Advisors LLC’s holdings in Oracle were worth $86,719,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in ORCL. Lockheed Martin Investment Management Co. grew its position in Oracle by 4.3% during the first quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider’s stock valued at $7,179,000 after buying an additional 2,110 shares during the period. Private Wealth Asset Management LLC raised its position in Oracle by 9.2% in the second quarter. Private Wealth Asset Management LLC now owns 3,817 shares of the enterprise software provider’s stock worth $835,000 after acquiring an additional 321 shares during the period. Soltis Investment Advisors LLC boosted its stake in Oracle by 4.8% in the second quarter. Soltis Investment Advisors LLC now owns 32,937 shares of the enterprise software provider’s stock valued at $7,201,000 after acquiring an additional 1,515 shares during the last quarter. Cascade Investment Group Inc. bought a new position in shares of Oracle during the 2nd quarter valued at approximately $239,000. Finally, Lockerman Financial Group Inc. bought a new position in shares of Oracle during the 2nd quarter valued at approximately $328,000. Institutional investors own 42.44% of the company’s stock.

Insider Buying and Selling at Oracle

In other Oracle news, Director Jeffrey Berg sold 49,365 shares of the company’s stock in a transaction dated Tuesday, October 28th. The stock was sold at an average price of $283.02, for a total value of $13,971,282.30. Following the transaction, the director directly owned 151,999 shares in the company, valued at $43,018,756.98. This represents a 24.52% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction dated Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the completion of the sale, the insider directly owned 132,656 shares in the company, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 204,254 shares of company stock valued at $60,227,807 over the last 90 days. Insiders own 40.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Stifel Nicolaus lifted their price target on shares of Oracle from $250.00 to $350.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Berenberg Bank raised their target price on Oracle from $202.00 to $306.00 and gave the stock a “hold” rating in a research report on Monday, September 15th. BMO Capital Markets set a $355.00 price target on Oracle and gave the company an “outperform” rating in a research report on Monday, October 13th. Erste Group Bank downgraded Oracle from a “buy” rating to a “hold” rating in a research note on Monday. Finally, Citigroup reissued a “buy” rating on shares of Oracle in a report on Friday, October 10th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $323.69.

Oracle Price Performance

ORCL stock opened at $241.02 on Tuesday. The firm has a 50 day moving average of $279.62 and a 200-day moving average of $232.02. The firm has a market capitalization of $687.10 billion, a P/E ratio of 55.79, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last posted its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. During the same quarter in the prior year, the company earned $1.39 earnings per share. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, sell-side analysts predict that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 0.8%. Oracle’s dividend payout ratio (DPR) is currently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.